Symbol Name ID |
Gba1
glucosylceramidase beta 1 MGI:95665 |
Darker colors indicate more annotations |
Human Phenotypes | Intracranial hemorrhage |
Microcephaly |
Hyposmia |
Orthostatic hypotension due to autonomic dysfunction |
Anorexia |
Dysphagia |
Oculomotor apraxia |
Spasticity |
Spastic paraparesis |
Spastic paraplegia |
Opisthotonus |
Frequent falls |
Gliosis |
Substantia nigra gliosis |
Hydrocephalus |
Ventriculomegaly |
Cerebral cortical atrophy |
Hypoplasia of the corpus callosum |
Cerebral atrophy |
Lewy bodies |
Spinal cord compression |
Neuronal loss in central nervous system |
Ataxia |
Limb ataxia |
Abnormality of extrapyramidal motor function |
Bradykinesia |
Parkinsonism |
Parkinsonism with favorable response to dopaminergic medication |
Myoclonus |
Tremor |
Resting tremor |
Paralysis |
Hemiplegia/hemiparesis |
Cranial nerve paralysis |
Abnormality of speech or vocalization |
Monotonic speech |
Dysarthria |
Depression |
Low frustration tolerance |
Delusion |
Anxiety |
Panic attack |
Schizophrenia |
Hallucinations |
Visual hallucination |
Apathy |
Reduced social reciprocity |
Personality changes |
Abnormal temper tantrums |
Impulsivity |
Agitation |
Restless legs |
Cognitive impairment |
Mental deterioration |
Dementia |
Frontal lobe dementia |
Progressive neurologic deterioration |
Short attention span |
Intellectual disability |
Micrographia |
Fluctuations in consciousness |
Sleep abnormality |
Insomnia |
Abnormality of movement |
Hyperreflexia |
Hyporeflexia |
Akinesia |
Hypokinesia |
Dyskinesia |
Dystonia |
Gait disturbance |
Broad-based gait |
Gait imbalance |
Shuffling gait |
Short stepped shuffling gait |
Postural instability |
Bulbar signs |
Encephalopathy |
Headache |
Developmental regression |
Global developmental delay |
Motor delay |
Sensorimotor neuropathy |
Seizure |
Bilateral tonic-clonic seizure |
Bilateral tonic-clonic seizure with generalized onset |
Generalized myoclonic seizure |
Abnormal autonomic nervous system physiology |
Disease(s) Associated with GBA1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gaucher's disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gaucher's disease perinatal lethal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gaucher's disease type I | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gaucher's disease type II | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gaucher's disease type III | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gaucher's disease type IIIC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
late onset Parkinson's disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lewy body dementia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Parkinson's disease |
Mouse Phenotypes | seizures |
abnormal microglial cell morphology |
abnormal brain morphology |
decreased brain size |
abnormal striatum morphology |
hippocampal neuron degeneration |
decreased cerebral cortex pyramidal cell number |
decreased Purkinje cell number |
astrocytosis |
abnormal neuron morphology |
neuron degeneration |
alpha-synuclein inclusion body |
|
Availability | Mouse Genotype | ||||||||||||
Gba1tm1.1Eginn/Gba1tm1.1Eginn | |||||||||||||
Gba1tm2.1Eginn/Gba1tm2.1Eginn | |||||||||||||
Gba1tm3Ggb/Gba1tm3Ggb | |||||||||||||
Gba1tm1Karl/Gba1tm1Karl Tg(Nes-cre)1Kln/? (conditional) |
|||||||||||||
Gba1tm2Karl/Gba1tm2Karl Tg(KRT14-cre)8Brn/? (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|